类风湿性关节炎相关的间歇性肺部疾病 (RA-ILD):关于患病率,危险因素,病原和治疗的最新情况
Daniel I Sullivan1, Dana P Ascherman2
1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh, UPMC Montefiore Hospital, 3459 Fifth Ave, NW 628, Pittsburgh, PA, 15213, USA. dsulliva@pitt.edu.
Current rheumatology reports
|September 25, 2024
概括
间歇性肺病 (ILD) 复杂化了类风湿性关节炎 (RA),增加了死亡率. 研究正在推进对RA-ILD病原体的理解,并探索新的治疗方法,但针对性治疗需要更多的分子洞察力.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 经常涉及间歇性肺部疾病 (RA-ILD),是致病率和死亡率的重要原因.
- 确定RA-ILD的患病率是具有挑战性的,因为诊断标准多样化,缺乏标准化查.
- 对疾病发病因子的理解有限,并且很少有验证的生物标志物阻碍了临床试验的开发.
研究的目的:
- 审查有关风湿性关节炎相关间歇性肺病 (RA-ILD) 的当前知识.
- 突出了解RA-ILD病变的进展,并确定潜在的治疗点.
- 讨论RA-ILD新出现的治疗方案.
主要方法:
- 综述了许多研究,重点关注临床,放射,遗传,分子和血清学标记.
- 对RA-ILD治疗中的免疫调节剂和抗纤维菌剂的研究分析.
- 综合目前对RA-ILD病原和治疗策略的理解.
主要成果:
- 研究已经确定了有价值的临床生物标志物,并提供了有关RA-ILD病原体的见解.
- 研究已经探索了潜在的治疗点,并评估了新的治疗选择,包括免疫调节剂和抗纤维菌剂.
- RA-ILD 仍然是 RA 患者过度发病和死亡的主要原因.
结论:
- RA-ILD显著影响RA患者的结果,需要进一步的研究.
- 了解分子病原学的进步对于开发向疗法至关重要.
- 对生物标志物和治疗剂的持续研究对于改善RA-ILD管理至关重要.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
01:17Other Pulmonary Disorders
807
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
807
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K